Market Overview

Stocks Hitting 52-Week Lows

Related MDCO
Bank Of America Q3 Small & Mid-Cap Biotech Preview
BACTIVTM Phase 3 SOLO II Trial Results Published In The Journal Clinical Infectious Diseases
Related NRX
Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest ROE
Stocks Hitting 52-Week Lows

The Medicines Company (NASDAQ: MDCO) shares touched a new 52-week low of $24.17 after the company provided an update on Angiomax patent litigation.

NephroGenex (NASDAQ: NRX) shares reached a new 52-week low of $6.67. On Monday, NephroGenex posted a full-year net loss of $6.3 million, or $19.71 per share.

Bio-Path Holdings (NASDAQ: BPTH) shares declined 5.66% to touch a new 52-week low of $2.50. Bio-Path shares have jumped 349.15% over the past 52 weeks, while the S&P 500 index has gained 19.24% in the same period.

Akers Biosciences (NASDAQ: AKER) shares reached a new 52-week low of $3.85. Akers Biosciences' trailing-twelve-month ROE is -41.12%.

Posted-In: 52-Week LowsNews Movers & Shakers Intraday Update Markets

 

Related Articles (BPTH + AKER)

Around the Web, We're Loving...

Get Benzinga's Newsletters